RBC Capital analyst Michael Harvey maintained a Hold rating on Paramount Resources (PRMRF – Research Report) yesterday and set a price target ...

RBC Capital analyst Michael Harvey maintained a Buy rating on ARC Resources (AETUF – Research Report) yesterday and set a price target of ...

The need for continued innovation to maintain a competitive edge remains paramount. The initial slow uptake of Casgevy could potentially strain CRISPR Therapeutics' financial resources.

RBC Capital Markets has promoted Adam Ragol-Levy to head of European and Asian product, multi-asset agency solutions. The appointment follows three years serving as global multi-asset product manager ...

RBC Capital Markets analyst Pammi Bir published a look ahead to 2025 for REITs and emphasized four top picks, Scotiabank analyst Ovais Habib expects significant profit margin growth for precious ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Tuesday, RBC Capital Markets adjusted its price target for Canadian Natural Resources Limited (TSX:CNQ:CN) (NYSE: CNQ), bringing it down to Cdn$62.00 from the previous Cdn$63.00. The company, ...

On Tuesday, RBC Capital Markets adjusted its price target for Canadian Natural Resources Limited (TSX:CNQ:CN) (NYSE: CNQ), bringing it down to Cdn$62.00 from the previous Cdn$63.00. The company ...